This assay is to provide COLO 205-based In Vitro Anti-Tumor Efficacy Assay to accelerate our client's oncology projects. The assay will be customized according to the specific requirements. Please contact our scientists to discuss more details.
Target Cell Name
COLO 205
Target Cell Organism
Human
Target Cell Background
The COLO 205 cell line is made up of epithelial cells isolated in 1975 from ascitic fluid derived from a 70-year-old, White, male with colon cancer. The cells can be used for cancer and toxicology research.
Related Diseases
Colorectal Adenocarcinoma; Colon Cancer
Research Area
Oncology
Assay Name
In Vitro Anti-Tumor Efficacy Assay
Short Description
COLO 205-cell based In Vitro Anti-Tumor Efficacy Assay
Assay Description
Tumor-derived cell lines have been the mainstay for anti-cancer drug discovery, and the assessment of in vitro efficacy is a common method to evaluate the anti-cancer efficacy with various kinds of therapeutic candidates.